ProShares UltraShort NASDAQ Biotechnology
7 hedge funds and large institutions have $938K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
7
Holding in Top 10
–
Calls
$43K
Puts
$16K
Top Buyers
| 1 | +$458K | |
| 2 | +$367K | |
| 3 | +$33K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.01K |
Top Sellers
No sellers this quarter